These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21791097)

  • 1. Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis.
    Andrés Cerezo L; Mann H; Pecha O; Pleštilová L; Pavelka K; Vencovský J; Senolt L
    Arthritis Res Ther; 2011 Jul; 13(4):R122. PubMed ID: 21791097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
    Nordal HH; Brun JG; Hordvik M; Eidsheim M; Jonsson R; Halse AK
    Scand J Rheumatol; 2016 Jul; 45(4):274-81. PubMed ID: 26767827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis.
    Chen YS; Yan W; Geczy CL; Brown MA; Thomas R
    Arthritis Res Ther; 2009; 11(2):R39. PubMed ID: 19284577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A8/A9 as a biomarker for synovial inflammation and joint damage in patients with rheumatoid arthritis.
    Kang KY; Woo JW; Park SH
    Korean J Intern Med; 2014 Jan; 29(1):12-9. PubMed ID: 24574827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated S100A8/A9 and S100A12 Serum Levels Reflect Intraocular Inflammation in Juvenile Idiopathic Arthritis-Associated Uveitis: Results From a Pilot Study.
    Walscheid K; Heiligenhaus A; Holzinger D; Roth J; Heinz C; Tappeiner C; Kasper M; Foell D
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7653-60. PubMed ID: 26624497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis.
    Nordal HH; Brokstad KA; Solheim M; Halse AK; Kvien TK; Hammer HB
    Arthritis Res Ther; 2017 Jan; 19(1):3. PubMed ID: 28081709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis.
    Brunner HI; Schulert GS; Sproles A; Thornton S; Cornejo GV; Antón J; Cuttica R; Henrickson M; Foeldvari I; Kingsbury DJ; Askelson M; Liu J; Mukherjee S; Wong RL; Lovell DJ; Martini A; Ruperto N; Grom AA;
    Arthritis Res Ther; 2024 Jun; 26(1):125. PubMed ID: 38918871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis.
    de Seny D; Fillet M; Ribbens C; Marée R; Meuwis MA; Lutteri L; Chapelle JP; Wehenkel L; Louis E; Merville MP; Malaise M
    Clin Chem; 2008 Jun; 54(6):1066-75. PubMed ID: 18436720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.
    Hinze CH; Foell D; Johnson AL; Spalding SJ; Gottlieb BS; Morris PW; Kimura Y; Onel K; Li SC; Grom AA; Taylor J; Brunner HI; Huggins JL; Nocton JJ; Haines KA; Edelheit BS; Shishov M; Jung LK; Williams CB; Tesher MS; Costanzo DM; Zemel LS; Dare JA; Passo MH; Ede KC; Olson JC; Cassidy EA; Griffin TA; Wagner-Weiner L; Weiss JE; Vogler LB; Rouster-Stevens KA; Beukelman T; Cron RQ; Kietz D; Schikler K; Mehta J; Ting TV; Verbsky JW; Eberhard AB; Huang B; Giannini EH; Lovell DJ
    Arthritis Rheumatol; 2019 Mar; 71(3):451-459. PubMed ID: 30225949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-related Protein 8/14 Levels in Rheumatoid Arthritis: Marker of Disease Activity and Response to Methotrexate.
    Patro PS; Singh A; Misra R; Aggarwal A
    J Rheumatol; 2016 Apr; 43(4):731-7. PubMed ID: 26834220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted proteomics reveals serum amyloid A variants and alarmins S100A8-S100A9 as key plasma biomarkers of rheumatoid arthritis.
    Nys G; Cobraiville G; Servais AC; Malaise MG; de Seny D; Fillet M
    Talanta; 2019 Nov; 204():507-517. PubMed ID: 31357327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [S100A8, S100A9 and S100A12 proteins in rheumatoid arthritis].
    Baillet A
    Rev Med Interne; 2010 Jun; 31(6):458-61. PubMed ID: 20398973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study.
    Hurnakova J; Hulejova H; Zavada J; Hanova P; Komarc M; Mann H; Klein M; Sleglova O; Olejarova M; Forejtova S; Ruzickova O; Vencovsky J; Pavelka K; Senolt L
    PLoS One; 2017; 12(8):e0183420. PubMed ID: 28832684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A8 and S100A12 Proteins as Biomarkers of High Disease Activity in Patients with Rheumatoid Arthritis That Can Be Regulated by Epigenetic Drugs.
    Roszkowski L; Jaszczyk B; Plebańczyk M; Ciechomska M
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease.
    Kim HA; An JM; Nam JY; Jeon JY; Suh CH
    J Rheumatol; 2012 Jul; 39(7):1399-406. PubMed ID: 22660800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Calprotectin Versus Acute-Phase Reactants in the Discrimination of Inflammatory Disease Activity in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors.
    Inciarte-Mundo J; Victoria Hernández M; Ruiz-Esquide V; Raquel Cabrera-Villalba S; Ramirez J; Cuervo A; Pascal M; Yagüe J; Cañete JD; Sanmarti R
    Arthritis Care Res (Hoboken); 2016 Jul; 68(7):899-906. PubMed ID: 26841119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis.
    Hurnakova J; Zavada J; Hanova P; Hulejova H; Klein M; Mann H; Sleglova O; Olejarova M; Forejtova S; Ruzickova O; Komarc M; Vencovsky J; Pavelka K; Senolt L
    Arthritis Res Ther; 2015 Sep; 17(1):252. PubMed ID: 26373925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy.
    Gernert M; Schmalzing M; Tony HP; Strunz PP; Schwaneck EC; Fröhlich M
    Arthritis Res Ther; 2022 Aug; 24(1):200. PubMed ID: 35986420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment.
    Davies JC; Midgley A; Carlsson E; Donohue S; Bruce IN; Beresford MW; Hedrich CM
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32723832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in serum interleukin-21 levels is associated with disease activity improvement in patients with recent-onset rheumatoid arthritis.
    Sglunda O; Mann HF; Hulejová H; Pecha O; Pleštilová L; RůŽičková O; Fojtíková M; Sléglová O; Forejtová S; Pavelka K; Vencovský J; Senolt L
    Physiol Res; 2014; 63(4):475-81. PubMed ID: 24702489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.